Approach to epilepsy in childhood by Wilmshurst, JM
Between 2000 and 2002, 1 087 children attended the epilepsy clinic at Red
Cross Children’s Hospital, accounting for over 60% of patients attending the pae-
diatric neurology clinics. Of these children, 45% had an underlying cause for
their epilepsy (symptomatic), while the remainder were cryptogenic or idiopathic.
In the symptomatic group the condition was potentially preventable in 63% and
included hypoxic ischaemic encephalitis, meningitis, tuberculomas, neurocysticer-
cosis and trauma. Of the total group15% had ‘intractable forms of epilepsy’ and
59% had a level of neurodisability which required the child to be placed in a
day care facility, training centre or to receive special needs education. Similar
results are found in other developing countries.3,4 However, at Red Cross
Children’s Hospital we are seeing only the ‘tip of the iceberg’ as many children
are managed at primary and secondary level. At least 50% children with epilep-
sy in developing countries are not treated, owing to a combination of lack of
access to medical resources and the continuing stigma around epilepsy.1-3
When does a child have epilepsy?
Any neurologically stressed individual can have a seizure, but this does not nec-
essarily mean s/he has epilepsy. A convulsion can occur as part of an intercur-
rent illness, transient hypoxia or biochemical imbalance. Unless brain injury
occurs epilepsy is unlikely to develop. Only in exceptional circumstances is a
child labelled epileptic after the first seizure (e.g. infantile spasm).
If there are 2 or more eye-witness descriptions of isolated seizure events then
epilepsy should be diagnosed, once acute reversible causes are excluded such
as electrolyte imbalance, hypoxia or infections. The attending physician should
try and define the type of epilepsy as early as possible. It is important to realise
that there are many other events that may be misdiagnosed as epilepsy, but are
in fact paroxysms (Table I).
What is the role of the general practitioner?
Epilepsy is a common disorder, and without primary level input and co-ordina-
tion, the secondary and tertiary services will not cope. Non-complex epilepsy
(e.g. absence, benign focal epilepsy of childhood) can be managed mainly by a
GP once a paediatrician has established the diagnosis and recommended treat-
ment. Complex epilepsies (e.g. infantile spasms, Lennox-Gastaut syndrome,
severe myoclonic epilepsy of infancy (SMEI)) need to be managed in collabora-
tion with the paediatrician and paediatric neurology services.
When to perform an EEG
An EEG should be requested after 2 or more seizures. It is helpful to request an
EEG either before or on the day of referral to the specialist. To gain maximum
information from the EEG, request an awake study with hyperventilation for sus-
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A small rural epidemiological study in the Northern Province described a prevalence
of epilepsy of 6.7 per 1 000 South African children.1 For the whole of Africa the
figure ranges between  2.9 and 26 per 1 000 children.1,2
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pected absence epilepsy and a sleep
study (sleep-deprive the child) for sus-
pected complex partial epilepsy.
Infantile spasms are a medical emer-
gency and an EEG must be performed
within 24 hours with no delay in start-
ing treatment.
Typical febrile convulsions do not need
an EEG, but a child with atypical fea-
tures may have generalised epilepsy
with febrile seizures (GEFS +), or
SMEI and an EEG may be useful. An
EEG is performed over a relatively
short period (usually 30 minutes), and
a normal study does not automatically
exclude epilepsy. If the history and/or
clinical picture is consistent with a
seizure disorder then the child should
be managed as such.
When to perform
neuroimaging
Whenever there are focal features to
the seizure, neuroimaging is recom-
mended to exclude a space-occupying
lesion, cerebral malformation or infec-
tive focus. Computed tomography (CT)
scanning is usually sufficient.
Other investigations
Exclude meningitis through CSF analy-
sis in any infant below 18 months of
age with a febrile convulsion, and
consider it in any other child who is
pyrexial. Avoid lumbar puncture if
there is any evidence of raised
intracranial pressure or focal patholo-
gy. In these cases perform neuroimag-
ing first. Acute seizures always war-
rant a blood glucose and acid-base
analysis. Metabolic screens are occa-
sionally needed but should be co-ordi-
nated through a tertiary centre.
Unusual features in the history or clini-
cal presentation suggest toxicology.
Neonatal seizures
Neonatal seizures are common and
often very subtle. The majority are
related to hypoxic ischaemic
encephalopathy (HIE), intracranial
haemorrhage, intracranial infection
and developmental anomalies. It is
essential to exclude treatable causes.
These are biochemical dysfunction,
infection and intraventricular or cere-
bral haemorrhage. First-line therapy is
phenobarbitone. Sodium valproate,
carbamazepine and the benzodi-
azepines are used in resistant cases.
Metabolic disorders are rare, but
should be considered once common
causes are excluded, especially with a
history of consanguinity or family his-
tory of neonatal seizures. Biotinidase
deficiency and pyridoxine dependency
are dramatically responsive to replace-
ment therapy.
Fig. 1 gives a summary of a simple
approach to the child presenting
acutely with convulsions.
Febrile convulsions
Febrile convulsions are seen in a child
with a pyrexial illness, with a clear
focus of infection, who has a gener-
alised convulsion for less than 5 min-
utes. The child should be more than
18 months old and clinically stable
with no focal neurology. Management
consists of reassurance, temperature
control and advice that the child may
have more seizures but will eventually
‘grow out of it’. Lumbar puncture must
be performed in all children below 18
months of age, and a CT scan must be
performed if there are focal features.
Fig. 1. Epilepsy flow chart (A = airway; B = breathing; C = cardiac; D = dextrostix / neurodisability; GCS = Glasgow coma
score; GTCS = generalised tonic-clonic seizures; CBZ = carbamazepine; Valp = sodium valproate; Pb = phenobarbitone; 
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Atypical febrile convulsions which per-
sist beyond 6 years of age are found
in a group of children, and have been
labelled GEFS +.5 The syndrome
ranges in severity from simple recur-
rent febrile convulsions which eventual-
ly resolve after 6 years of age, to a
severe seizure disorder with additional
events of afebrile generalised seizures,
myoclonic and drop attacks. Several
gene loci for this condition have been
identified and SMEI is the worst end of
the spectrum.
TYPES OF EPILEPSY
The International League Against
Epilepsy (ILAE) has devised systems for
categorising epilepsy.6 This falls into 3
main groups — focal, generalised and
syndromic, further subdivided into
symptomatic, idiopathic and crypto-
genic. This categorisation of epilepsy
allows more directional treatment and
consequently better long-term prog-
noses. This article will cover only the
commoner forms and those which
have the most impact (see also Tables
I - III for details of each type).
Focal epilepsy (Table II)
The focal epilepsies are the predomi-
nant group of epilepsies in children
over 6 years of age.7 In simple partial
seizures consciousness is preserved,
with loss of consciousness during com-
plex partial seizures. Episodes last 30
seconds to a few minutes. The child




Temporal lobe epilepsy can be very
resistant to medical therapy, especially
if associated with mesial temporal
sclerosis, with or without a history of
prolonged febrile convulsions. This
form of epilepsy can be debilitating
and progress into adulthood. It is
increasingly managed surgically.
The commonest symptomatic focal
epilepsies in South Africa are due to
neurocysticercosis and tuberculosis
granulomas. In most patients seizures
are isolated and do not require treat-
ment. For recurrent seizures, carba-
mazepine is the first-line agent in sec-
ondary and tertiary facilities. However
phenobarbitone may be used in the
child from an isolated region without
easy access to medical facilities.
Generalised epilepsy (Table III)
Children between 1 and 6 years are
more likely to have a generalised form
of epilepsy.7 Generalised tonic clonic
seizures in children below 1 year of
age are rare. There is an association
with various metabolic and neuro-
degerative conditions, so early referral
should be considered, especially if
there is any evidence of neuroregres-
sion. Treatment is with either sodium
valproate or carbamazepine.
Table I. Paroxysmal events
Reflex anoxic attacks (‘breath-holding attacks’) — shared care GP/paediatrician
• Common
• Toddler to 6-year-old age group
• Vagally mediated, usually triggered by crying or pain
• The child takes a deep gasp, stops breathing, becomes pale or blue with brief loss of consciousness
• Spontaneously recovers and no neurological sequelae are evident
• Management: reassurance (difficult to give unless the parent has experienced a series of episodes and knows the 
child always fully recovers)
• Differential diagnoses: sepsis, seizures, metabolic conditions, cardiac arrhythmias and Munchausen’s syndrome by 
proxy
• Events are exacerbated by iron deficiency anaemia and a trial of iron therapy should be considered
Syncope (fainting) — shared care GP/paediatrician
• Common in adolescent girls but can affect all age groups
• Vagally mediated
• Attacks can be very abrupt and easily confused with seizures
• Exclude long QT interval
Benign paroxysmal vertigo — shared care GP/paediatrician
• Toddlers
• Appear pale and frightened, run to a carer and cling to them and may vomit
• Last no more than a few minutes and the child appears completely well afterwards
• Differential diagnosis is temporal lobe epilepsy (request a sleep EEG)
Pseudoseizures — shared care GP/paediatrician
• A diagnosis of exclusion
• Commonest in adolescent girls
• Dramatic with rolling on the ground, random flinging about of limbs with eyes closed
• Incontinence can occur
• Children with confirmed epilepsy also can have pseudoseizures
• Events may represent a response to abuse (often sexual)
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Table II. Focal epilepsies
Benign focal epilepsy of childhood (BFEC, Rolandic epilepsy) — shared care GP/paediatrician
• Commonest form of childhood focal epilepsy
• Onset is typically between 8 and 12 years of age
• Onset is often from sleep and the child has focal motor facial twitching which rarely has secondary generalisation
• The child is usually aware during the event but cannot talk until the seizure terminates
• Events are usually short and infrequent
• Not all patients require therapy; those that do have a good response to carbamazepine
• Seizures resolve after adolescence
Benign epilepsy with occipital paroxysms (BEOP) — shared care GP/paediatrician
• The second commonest form of childhood focal epilepsy
• Events are very infrequent, typically from sleep and can be prolonged
• Often visual manifestations or temporary blindness, intense headache and vomiting occur during the event
• The EEG shows typical occipital paroxysms
• Therapy is not always necessary and the natural history is for spontaneous resolution
Table III. Generalised epilepsies
Childhood absence epilepsy (CAE) — shared care GP/paediatrician
• Commonest form  
• Onset 4 - 6 years
• Brief episodes of unresponsiveness (no more than 10 seconds) and gross motor arrest
• May be simple automatisms and resolution typically by adolescence
Juvenile myoclonic epilepsy (JME) — shared care GP/paediatrician
• Commonest adolescent form of epilepsy
• Onset between 8 and 14 years
• Often photosensitivity and check for myoclonus on awakening
Atypical absences — shared care paediatrician/paed neurologist
• Prolonged with atypical EEG features
• Associated with various epilepsy syndromes
• Poorer cognitive outcome
• Medication is with sodium valproate as first line after exclusion of a metabolic condition
Tonic seizures — shared care paediatrician/paed neurologist
• Occurs in isolation or as part of epilepsy syndromes
• Difficult seizures to control
• May be associated with serious autonomic dysfunction
• First-line treatment is with carbamazepine
Myoclonic seizures — shared care paediatrician/paed neurologist
• Short (microseconds) of muscular contraction, typically involving the arms, head and trunk
• Events range from a head nod to being thrown across the room
• These children often need helmets
• Referral to a specialised neurology unit is warranted, especially if there is neuroregression and/or ataxia
Drop attacks — shared care paediatrician/paed neurologist
• Usually associated with epilepsy syndromes
• Tonic (stiff fall) or atonic (droop fall/slump)
• Episodes are short and not associated with post-ictal drowsiness
• Child appears surprised, picks himself up and continues his activities
• Rarely benign and these children should be referred to a neurologist
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The differentiation between complex
partial seizures and absence epilepsy
is important. The former is treated with
carbamazepine, and the latter with
sodium valproate. Treating a child
who has absence epilepsy with carba-
mazepine may cause absence status.
Epilepsy syndromes (Table IV)
Many epilepsy syndromes are now
recognised; however, infantile spasms,
severe myoclonic epilepsy of infancy,
Lennox-Gastaut syndrome and Landau-
Kleffner syndrome (LKS) are the most
relevant, since they have major neuro-
cognitive impact.
Status epilepticus
This is defined as a generalised con-
vulsion that lasts 30 minutes or more.
It can occur as continuous seizure
activity or the child may go in and out
of ictus, with the concomitant risk of
sustained brain damage. Management
is summarised in Fig. 2. The following
alternatives can be considered: 
• Lorazepam (0.1 mg/kg) is a faster
acting alternative to diazepam for
bolus IV intervention. 
• Midazolam intranasally (200
µg/kg) or sublingually (500 µg/kg)
if there is no venous access.
Fig. 2. Management of status epilepticus. ABCD (oxygen, monitor saturation, pulse
and blood pressure, glucose). (PR = per rectum; FBC = full blood count; 
IO = intraosseus; PICU = paediatric intensive care unit.)
Table IV. Epilepsy syndromes
Infantile spasms — shared care paediatrician/paed neurologist
• True neurological emergencies
• Onset between 3 and 6 months
• Often misdiagnosed as colic
• Infant has runs of head and trunk flexion and arms and legs ‘flinging out’ with the contraction held for 1 - 2 seconds
• The episode distresses the baby, there is usually a cry
• These children are undergoing a degenerative neuroencephalopathic process (West syndrome)
• Delay in gaining seizure control will be reflected in the severity of the outcome
• Immediate admission with EEG performed the same day (to confirm hypsarrhythmia and burst suppression)
• Management: Steroids (ACTH) in South Africa; alternative — vigabatrin. Long-term management usually with 
sodium valproate and a benzodiazepine
• Neurometabolic investigations and neuroimaging to exclude tuberous sclerosis unless a clear underlying aetiology 
is evident, e.g. history of birth asphyxia
Severe myoclonic epilepsy of infancy — shared care paediatrician/paed neurologist
• Onset < 1 year of age
• Clusters of atypical febrile convulsion
• Later afebrile generalised tonic-clonic and myoclonic events
• Neuroregression often follows by 2 years of age
Lennox-Gastaut syndrome — shared care paediatrician/paed neurologist
• Can occur independently or follow on from infantile spasms (West syndrome)
• Onset from 2 years of age
• Combination of drop attacks, myoclonic seizures and occasional generalised tonic-clonic seizures
Landau-Kleffner syndrome — shared care paediatrician/paed neurologist
• Presents around 2 years of age in a previously normal child
• In a child with normal hearing who has lost expressive and receptive language over a few days to weeks consider 
LKS and perform a sleep EEG
• Diagnosis of this rare condition requires early specialist intervention
PR diazepam (0.5 mg/kg)
↓
IV access IV diazepam (0.3 mg/kg)
(take bloods for glucose, gas, electrolytes, FBC and culture)
Access failure/delay — gain IO acces or
Intranasal midazolam 200 µg/kg
↓
IV phenobarbitone (20 mg/kg)
↓
Repeat phenobarbitone (10 mg/kg)
↓
Repeat phenobarbitone (10 mg/kg)
↓
Refer to PICU for intubation and sodium pentothal infusion
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• Midazolam infusion loading at 200
µg/kg by slow IV injection, then
titrating an infusion between 30 -
300 µg/kg/h. Alternatively, clon-
azepam (Rivotril) infusion if seizure
control is not gained after the first
phenobarbitone infusion.
• Phenytoin (20 mg/kg over 20 min-
utes) if there is a known adverse
reaction to phenobarbitone (moni-
tor for cardiac arrhythmias).
Watch carefully for drug-related respi-
ratory depression. Intubation, ventila-
tion and administration of sodium pen-
tothal infusion should only be per-
formed in a centre with trained anaes-
thetic and paediatric intensive care.
TREATMENT
Routine medication
Phenobarbitone is the cheapest and
most readily available agent in South
Africa for routine treatment of epilepsy
and for non-complex seizure disorders
in children who are not based near a
tertiary or secondary centre it is better
to use this than nothing at all. There is
also a place for phenobarbitone in
children with profound brain damage,
such as those with cerebral palsy with
static encephalopahy. A daily dose of
phenobarbitone given to a medically
resistant child can make all the differ-
ence to quality of life. For older chil-
dren phenobarbitone is associated
with hyperactivity, poor concentration
and behavioural problems. Parents
must be warned of this and asked to
report these features early.8
Agents routinely used internationally
and increasingly in South Africa, are
sodium valproate and carbamazepine.
Traditionally generalised seizure disor-
ders are treated with sodium val-
proate, while partial epilepsies are
treated with carbamazepine.
Carbamazepine exacerbates absence
and myoclonic forms of epilepsy.
Sodium valproate should be used with
caution in children under 1 year and
in those with suspected metabolic dis-
orders. Drug levels are unhelpful
unless there is suspected toxicity or
lack of compliance. Ethosuximide is
used mainly for patients with absence
epilepsy resistant to, or intolerant of,
valproate.
The benzodiazepines have roles in
both acute and chronic epilepsy.
Diazepam is used routinely in status
epilepticus. Alternatives are midazo-
lam, which can be used intranasally
and sublingually, and lorazepam.
Clonazepam or clobazam are used
long-term, and are both very good for
myoclonic and drop attacks. Tolerance
tends to develop after 3 months and
drug ‘holidays’ are helpful.
Second-line agents are lamotrigine,
topiramate, gabapentin and vigaba-
trin.9 Lamotrigine has had a major
impact on children with resistant
seizure disorders — especially those
with Lennox-Gastaut syndrome. It is
expensive and only available to chil-
dren with access to tertiary centres.
Topiramate is described particularly
for partial epilepsies and more recent-
ly for infantile spasms. It can cause
dramatic loss of appetite and must be
dose-titrated carefully. Vigabatrin is an
effective agent for structural lesions
and infantile spasms but  has lost
favour since visual field defects were
described. It also has serious effects
on behaviour. Other new agents on
the market include levitiracetam, which
may be very effective in photosensitive
forms of epilepsy.
Alternative therapies include trials of
biotin, pyridoxine and folate, most
effective in the neonatal and infancy
period, but there are cases of pyridox-
ine-responsive epilepsies in older chil-
dren. Acetazolamide has a role in resist-
ant epilepsies. Steroids can be used as
a 6-week course and there is anecdotal
evidence for weekly treatment in some
forms of epilepsy (continuous spike
wave in sleep (CSWS), LKS).
How long to treat for
Generally a 2-year seizure-free period
is recommended before trying gently
to wean off medication. Shorter cours-
es are acceptable for tuberculomas
and neurocysticercosis where disease
activity is limited. Similarly children
who required prophylaxis during acute
admission, e.g. seizures as part of a
head injury or meningitis, often have
resolution of epileptogenic activity
within 3 months unless a brain lesion
persists. Parents should be warned
that some forms of epilepsy do not
remit, such as juvenile myoclonic
epilepsy and Lennox-Gastaut syn-
drome.
Intractable epilepsy
Intractable epilepsy describes persist-
ent seizures despite the use of 2 or
more agents. In reality it is often not
the seizures that are debilitating, but
the impact they have on the child and
the family. The problems of sleepless
nights, post-ictal drowsiness and irrita-
tion, poor concentration in class,
drowsiness and other side-effects from
the drugs, and lack of independence
in adolescence with over-protection
from parents, have often driven practi-
tioners to look at alternative treat-
ments.
Alternatives to medication
Complex patients with intractable
epilepsy should be managed within
the paediatric neurology service
where they can have an ‘epilepsy
work-up’. This includes a combination
of video EEG telemetry, neuroimaging
and metabolic investigations to define
the epilepsy semiology. From these
data, as well as the patients’ clinical
findings and drug history, candidates
for surgery, or those who are better
suited to a trial of ketogenic diet,10 are
selected.
Epilepsy is a common dis-
order, and without primary
level input and co-ordina-
tion, the secondary and
tertiary services will not
cope.
If there are 2 or more eye-
witness descriptions of iso-
lated seizure events then
epilepsy should be diag-
nosed, once acute rever-
sible causes are excluded
such as electrolyte imbal-
ance, hypoxia or infections.
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Ketogenic diet
Use of the ketogenic diet for epilepsy
control dates back to biblical times.10
Over the last 20 years it has become
popular again. The diet undoubtably
works although its mechanism has not
been established. The literature sug-
gests success in a third of patients.
The diet requires significant support
from an experienced dietician since
remaining in ketosis at 3 to 4+ is
essential. A 3-month trial period is 
recommended, after which, if the diet
is tolerated and successful, it is used
for 2 years, followed by a 6-month
weaning period. We have had no
major complications in our group of
patients and growth has continued
despite the strictness of the regimen.
Surgery
Epilepsy surgery may represent the
only true potential cure for a child
with epilepsy.11 Interventions may be
divided into resection (removal of
abnormal tissue) and isolation (discon-
nection of the focus from the rest of
the brain). The vagal nerve stimulator
device is used in those patients with
resistant epilepsy who do not have a
surgical focus.12 It is not a cure but
appears to reduce seizures by up to
50% with a maximum benefit after 1 -
2 years. The device is fitted in a simi-
lar way to a pacemaker and has mini-
mal side-effects. Parents claim that
these children have better quality of
life and improved mood. The main
issue is the high cost, and in South
Africa it is difficult to justify such
expenditure within the government 
sector.
Genetics of epilepsy
This is a rapidly expanding field.13 In
general most inherited (idiopathic)
forms of epilepsy are relatively
benign. Marked seizure type hetero-
geneity can occur within the same
family and this highlights the need for
a detailed family tree. Such informa-
tion is often withheld due to the stigma
attached to epilepsy and failure to
recognise odd ‘blackouts’ as seizures
in distant family members.
Support groups
Epilepsy South Africa is a national
organisation that provides immense
support to children and adults with
epilepsy and their carers. They offer
family and individual counselling, as
well as educational support to schools
and community centres. They support
the hospital service visiting during clin-
ic times and attempt to link the hospi-
tal and community. Webpage:
www.epilepsy.org.za
References available on request.
Childhood epilepsy is the common-
est condition in paediatric neurolo-
gy clinics.
Over 60% of the symptomatic caus-
es are avoidable.
60% of epileptics have an associat-
ed neurodisability.
Over 50% of children with epilepsy
do not receive medication.
The ‘treatment gap’ is related to
lack of medical resources and stig-
ma associated with epilepsy.
Label a child epileptic only after
two seizures and then request an
EEG.
A normal EEG does not exclude
epilepsy.
Infantile spasms are neurological
emergencies.
Epilepsy surgery is successfully
practised on selected patients in the
government sector.
Patients with complex or intractable




A study of over 400 000 veterans
show that they have a 60% greater
chance than normal of developing
amyotrophic lateral sclerosis
(AML). The study, by a team from
Harvard, looked at men who
served in the US forces in World
War I and II, the Korean war and
the Vietnam war. Those whose
service took in more than one con-
flict had nearly double the risk of
developing AML. The risk was
independent of the military force
served in. However, even among
veterans, the disease is very rare,
researchers stress. The cause of the
increased risk is not known. About
10% of cases are inherited, but the
cause of the more common spo-
radic form has not been identified.
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